Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease...

Area of Science:

• Neuroscience
• Pathology
• Pharmacology

Background:

• Parkinson's disease (PD) research is limited by animal models that don't fully capture all disease aspects.
• Existing 6-hydroxydopamine (6-OHDA) models primarily focus on the nigrostriatal region, neglecting extra-nigrostriatal areas crucial for early PD symptoms.

Purpose of the Study:

• To characterize the full extent of neurodegeneration caused by 6-OHDA infusion in a mouse model.
• To investigate the spatiotemporal progression of pathology and associated neuroinflammatory and apoptotic responses.
• To explore potential sex differences in 6-OHDA-induced pathology.

Main Methods:

• Unilateral 6-OHDA infusion into the dorsal striatum of C57BL/6 mice at varying dosages (5, 10, 20 μg).
• Immunolabeling and advanced brain clearing techniques (iDISCO+) for whole-brain imaging.
• Light sheet microscopy, functional MRI (fMRI), and machine learning for data analysis.

Main Results:

• 6-OHDA infusion led to widespread loss of tyrosine hydroxylase-positive neurons and fibers throughout the brain, not just in the nigrostriatal region.
• Detailed spatiotemporal mapping of neurodegeneration and associated molecular changes was achieved.
• Sex differences in pathological outcomes were observed.

Conclusions:

• The 6-OHDA mouse model exhibits more widespread pathology than previously recognized, impacting extra-nigrostriatal regions.
• This comprehensive analysis provides a more complete picture of 6-OHDA-induced pathology, crucial for improving PD models.
• Findings can inform the design of future PD studies and the development of neurotherapeutics.